biotech
Bristol Meyers Squibb Enters NeoPhore Series B Round
The British biotech closes the round at £35 million with the participation of Italian investors Claris, Neva, Liftt, Club degli investitori, IAG
The British biotech closes the round at £35 million with the participation of Italian investors Claris, Neva, Liftt, Club degli investitori, IAG